Multiparametric MRI and Radiomics to Predict HER2-Low Cancer: The Potential Therapeutic Impact
- PMID: 37526546
- DOI: 10.1148/radiol.231649
Multiparametric MRI and Radiomics to Predict HER2-Low Cancer: The Potential Therapeutic Impact
Comment on
-
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.Radiology. 2023 Aug;308(2):e222646. doi: 10.1148/radiol.222646. Radiology. 2023. PMID: 37526540
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
